Ironwood Pharmaceuticals Inc
IRWD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001446847
In the last 90 days, Ironwood Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 212 institutions reported holding it in 13F filings for Q2 2026, worth $675.8M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Ironwood Pharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 240
- +26 vs. Q1 2022
- Shares held
- 175.0M
- +9.71M (+5.9%) vs. Q1 2022
- Total value
- $2.02B
- −$57.8M (−2.8%) vs. Q1 2022
- New holders
- 56
- 76 more added
- Sold out
- 30
- 78 more reduced
7 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRWD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $675.8M |
| Q1 2026 | 227 | $566.8M |
| Q4 2025 | 199 | $520.2M |
| Q3 2025 | 166 | $194.9M |
| Q2 2025 | 155 | $104.9M |
| Q1 2025 | 200 | $228.5M |
| Q4 2024 | 223 | $727.5M |
| Q3 2024 | 221 | $673.7M |
| Q2 2024 | 227 | $1.12B |
| Q1 2024 | 261 | $1.50B |
| Q4 2023 | 251 | $1.89B |
| Q3 2023 | 249 | $1.56B |
| Q2 2023 | 252 | $1.77B |
| Q1 2023 | 255 | $1.74B |
| Q4 2022 | 250 | $2.08B |
| Q3 2022 | 245 | $1.76B |
| Q2 2022 | 240 | $2.02B |
| Q1 2022 | 221 | $2.09B |
| Q4 2021 | 212 | $2.00B |
| Q3 2021 | 229 | $2.32B |
| Q2 2021 | 209 | $2.25B |
| Q1 2021 | 210 | $1.91B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Ironwood Pharmaceuticals Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price Jennifer C. | 520,000 | $6.00M | 1.02% | +520,000 | New |
| 13D Management LLC | 600,431 | $6.92M | 3.06% | +37,328+6.6% | Added |
| Ameriprise Financial Inc | 613,021 | $7.07M | 0.00% | +583,941+2,008.1% | Added |
| Two Sigma Advisers, LP | 641,600 | $7.40M | 0.02% | −76,700−10.7% | Reduced |
| JPMorgan Chase & Co | 717,404 | $8.27M | 0.00% | −75,396−9.5% | Reduced |
| Great Lakes Advisors, LLC | 736,648 | $8.49M | 0.17% | −11,039−1.5% | Reduced |
| D. E. Shaw & Co., Inc. | 751,429 | $8.66M | 0.01% | −434,953−36.7% | Reduced |
| Two Sigma Investments, LP | 859,494 | $9.91M | 0.03% | −29,394−3.3% | Reduced |
| Pacer Advisors, Inc. | 933,166 | $10.8M | 0.08% | +933,166 | New |
| Bridger Management, LLC | 956,014 | $11.0M | 2.48% | +26,300+2.8% | Added |
| Goldman Sachs Group Inc | 992,127 | $11.4M | 0.00% | −1,625,784−62.1% | Reduced |
| American Century Companies Inc | 1,058,120 | $12.2M | 0.01% | +398,840+60.5% | Added |
| Millennium Management LLC | 1,080,972 | $12.5M | 0.02% | +28,858+2.7% | Added |
| Charles Schwab Investment Management Inc | 1,124,738 | $13.0M | 0.00% | −303,443−21.2% | Reduced |
| Invesco Ltd. | 1,210,200 | $14.0M | 0.00% | +529,734+77.8% | Added |
| Principal Financial Group Inc | 1,227,803 | $14.2M | 0.01% | +972,231+380.4% | Added |
| Glenmede Trust Co NA | 1,304,913 | $15.0M | 0.09% | −141,986−9.8% | Reduced |
| Norges Bank | 1,437,734 | $16.6M | 0.00% | −1,613,987−52.9% | Reduced |
| Royce & Associates LP | 1,493,637 | $17.2M | 0.18% | +332,791+28.7% | Added |
| New York State Common Retirement Fund | 1,630,644 | $18.8M | 0.02% | −190,812−10.5% | Reduced |
| Northern Trust Corp | 1,638,893 | $18.9M | 0.00% | +17,553+1.1% | Added |
| Bank of New York Mellon Corp | 1,666,065 | $19.2M | 0.00% | +591,516+55.0% | Added |
| Jupiter Asset Management Ltd | 2,109,530 | $24.3M | 0.34% | +232,803+12.4% | Added |
| Nuveen Asset Management, LLC | 2,247,756 | $25.9M | 0.01% | +28,183+1.3% | Added |
| Westfield Capital Management Co LP | 2,316,128 | $26.7M | 0.21% | −6,218,288−72.9% | Reduced |
| Morgan Stanley | 2,577,531 | $29.7M | 0.00% | +293,707+12.9% | Added |
| Geode Capital Management, LLC | 2,615,039 | $30.2M | 0.00% | −143,697−5.2% | Reduced |
| Dimensional Fund Advisors LP | 3,079,290 | $35.5M | 0.01% | +4,760+0.2% | Added |
| Deutsche Bank AG | 3,442,750 | $39.7M | 0.02% | +2,770,309+412.0% | Added |
| Credit Suisse AG | 4,421,528 | $51.0M | 0.05% | −43,520−1.0% | Reduced |
| Putnam Investments LLC | 4,901,198 | $56.5M | 0.10% | +110,002+2.3% | Added |
| Renaissance Technologies LLC | 5,415,353 | $62.4M | 0.07% | +2,292,300+73.4% | Added |
| LSV Asset Management | 7,479,157 | $86.2M | 0.19% | +71,827+1.0% | Added |
| State Street Corp | 10,886,805 | $125.5M | 0.01% | +2,589,738+31.2% | Added |
| Brown Capital Management LLC | 11,641,935 | $134.2M | 1.80% | −2,587,064−18.2% | Reduced |
| Vanguard Group Inc | 14,479,824 | $167.0M | 0.00% | +1,123,496+8.4% | Added |
| Wellington Management Group LLP | 14,917,954 | $172.0M | 0.03% | −263,693−1.7% | Reduced |
| Sarissa Capital Management LP | 16,390,000 | $189.0M | 19.02% | 00.0% | Unchanged |
| BlackRock Inc. | 26,890,220 | $310.0M | 0.01% | +12,353,461+85.0% | Added |
| International Biotechnology Trust PLC | 692 | – | – | +692 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −836,648−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −710,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −172,062−100.0% | Sold out |
| APG Asset Management N.V. | 0 | $0 | 0.00% | −187,800−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −153,198−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −113,600−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −105,858−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −102,785−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −92,587−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −85,687−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −55,100−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −39,779−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −36,263−100.0% | Sold out |
| Zeke Capital Advisors, LLC | 0 | $0 | 0.00% | −28,345−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −24,117−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −22,643−100.0% | Sold out |
| Evercore Wealth Management, LLC | 0 | $0 | 0.00% | −22,425−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −18,354−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −15,214−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −15,104−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −13,613−100.0% | Sold out |
| Financial Counselors Inc | 0 | $0 | 0.00% | −10,660−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,540−100.0% | Sold out |
| Lake Point Wealth Management | 0 | $0 | 0.00% | −735−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −663−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Aaron Wealth Advisors | 0 | $0 | 0.00% | −3,648−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Price Michael F | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |